Grisnilimab Biosimilar - Anti-CD7 Antibody - Low endotoxin, Azide free (A323488)

Recombinant human monoclonal antibody to CD7 for ELISA, FACS, Functional Assay and In Vivo.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Grisnilimab Biosimilar - Anti-CD7 Antibody - Low endotoxin, Azide free
Description
Recombinant human monoclonal antibody to CD7.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG2SA - Human IgG2 with S387A mutation
Light Chains
lambda
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 144.72 kDa.
Purity
> 90% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
CD27 ligand, CD27-L, CD27L, CD27LG, CD70, CD70 antigen, GP40, T-cell antigen CD7, T-cell leukemia antigen, T-cell surface antigen Leu-9, TNFSF7, TP41, Tumor necrosis factor ligand superfamily member 7
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Grisnilimab Biosimilar - Anti-CD7 Antibody - Low endotoxin, Azide free (A323488)? Please let us know so that we can list the citation on this page.

Alternative products to Grisnilimab Biosimilar - Anti-CD7 Antibody - Low endotoxin, Azide free (A323488)